Va. Suits Alleging Janssen Cancer Drug 'Monopoly' Sent To NJ
A Virginia federal judge on Friday combined several class actions accusing Janssen Biotech of monopolizing sales of cancer drug Zytiga and sent them to New Jersey, saying not only does the...To view the full article, register now.
Already a subscriber? Click here to view full article